Wuxi AppTec Co Ltd

603259

Company Profile

  • Business description

    Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services throughout the discovery, development, and manufacturing spectrum for small molecule drugs, development of computer software and databases as well as consulting services for combinatorial chemistry and pharmaceuticals. The services offered by the company include drug research and development testing, clinical research services, an end-to-end CRDMO platform for peptide, oligonucleotide, and small molecules, and integrated biology services and solutions for drug discovery. The company's reportable segments are WuXi Chemistry, which derives maximum revenue, WuXi Testing, WuXi Biology, and Others. Geographically, it derives key revenue from the United States of America, followed by China, Europe, and other regions.

  • Contact

    288 Fute Zhong Road
    Waigaoqiao Free Trade Zone
    Pudong New Area
    Shanghai200131
    CHN

    T: +86 2150461111

    https://www.wuxiapptec.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2026

    Employees

    37,832

Stocks News & Analysis

stocks

Meta earnings: Strong end to 2025 as AI monetization begins to show

Investors please with latest results.
stocks

Why doesn’t the market like the earnings from this US tech giant?

Good quarter with AI demand ramping.
stocks

Our Tesla fair value increases meaningfully

Progress on Robotaxi and Optimus shows real world AI growth.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,164.8094.40-1.02%
CAC 408,126.5355.170.68%
DAX 4024,538.81229.350.94%
Dow JONES (US)48,835.80235.76-0.48%
FTSE 10010,223.5451.780.51%
HKSE27,387.11580.98-2.08%
NASDAQ23,468.98216.14-0.91%
Nikkei 22553,322.8552.75-0.10%
NZX 50 Index13,423.1874.570.56%
S&P 5006,934.7134.30-0.49%
S&P/ASX 2008,869.1086.00-0.96%
SSE Composite Index4,117.9540.04-0.96%

Market Movers